background image

Mantle Cell Lymphoma Clinical Trials

Find clinical trials for mantle cell lymphoma. Search for mantle cell lymphoma clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

for
Mantle Cell Lymphoma (MCL)
Location: Milwaukee WI
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06788652

Recruiting

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

for
Diffuse Large B-Cell Lymphoma,
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT03147885

Phase1, Phase2, Recruiting

IKS03 in Patients with Advanced B Cell Non-Hodgkin Lymphomas

for
B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma,
Location: Baltimore MD, Montréal
Sponsor: Iksuda Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT05365659

Phase1, Recruiting

A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

for
Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL),
Location: Duarte CA, Chicago IL, Rochester MN, Omaha NE, Portland OR,
Sponsor: MEI Pharma, Inc.

Sex: All

Age: 18+

Code: NCT03547115

Phase1, Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Duarte CA, Denver CO, Chicago IL, Bethesda MD, Nashville TN,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04830137

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

for
Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04883437

Phase2, Recruiting

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

for
Follicular Lymphoma, Mantle Cell Lymphoma, Hairy Cell Leukemia,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT06340737

Phase1, Recruiting

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

for
Mantle Cell Lymphoma
Location: Vancouver, Halifax, Toronto, Quebec City
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04566887

Phase2, Recruiting

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

for
B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma,
Location: Valhalla NY
Sponsor: New York Medical College

Sex: All

Age: 12 - 70

Code: NCT04491370

Phase1, Phase2, Recruiting

Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

for
Mantle Cell Lymphoma
Location: San Francisco CA
Sponsor: C. Babis Andreadis

Sex: All

Age: 18+

Code: NCT06252675

Phase2, Recruiting